Thomas Martin, Md

This is an early-stage study to check the safety of a new treatment called anti-BCMA CAR-T cell therapy for people with multiple myeloma that has come back or stopped responding to other drugs. Doctors will collect a patient's own immune cells, modify them in a lab to better targ…